OssDsign AB (publ) (OSSD) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to today's FineWire broadcast presentation with Host Design. After presentation, there will be a question and answer session. So if you have any questions, you can submit them using the form on the right. With that said, I'll hand the floor to you, CEO Mark Volk or CFO Anders Svensson. Please go ahead. Thank you. Thank you. Welcome, everyone. My name is Mark Waugh, and I'm the new CEO of AusDesign, effective January 1st of this year. I have with me our CFO, Anders Vinson. Today, we want to walk you through our fourth quarter and full year 2025 results. As always, when we do these presentations, the normal disclaimer. Before we go into the details, let me give you my view of the highlights in the quarter. First, we continue to see strong growth. Constant currency growth in U.S. dollar sales for Q4 was 24% and reported 9%. Although this predates my tenure with AustDesign, I'm very proud of the team's achievement of full-year constant currency growth of 45% or reported 35% due to the U.S. dollar to SEC exchange rate fluctuations. Two, it's worth noting that the optics quarter over quarter are still skewed by further deterioration in the U.S. dollar to SEC exchange rate. We've seen further erosion in the U.S. dollar, which impacts our reported figures in SEC, given our sales are generated in U.S. dollars. Three, we continue to generate strong gross margins, and we saw further improvement in adjusted EBIT levels net of some transition costs we incurred with our CEO change. During the quarter, we saw an additional publication of Ostazine Catalyst and a challenging revision foot and ankle case showing rapid bone ingrowth. This confirms, again, the potential for wider application in adjacent orthopedic segments. We also gained access in two new Western Regi...